Understanding how certain treatments can improve red blood cell production in children with Diamond-Blackfan anemia.
Regulating proliferation and differentiation of erythroid progenitors
This study is looking at how a type of medicine called glucocorticoids can help kids with Diamond-Blackfan anemia make more red blood cells by understanding how it affects certain cells in their bone marrow, with the hope of finding better treatments for them.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11128283 on NIH RePORTER |
What this research studies
This research focuses on Diamond-Blackfan anemia (DBA), a condition that causes bone marrow failure and affects red blood cell production in children. The study investigates how glucocorticoids, a type of medication, can enhance the production of red blood cells by influencing the development of specific progenitor cells in the bone marrow. By examining the genetic and cellular mechanisms involved, the research aims to clarify how these treatments work and to identify potential new therapeutic targets. The findings could lead to improved treatment strategies for DBA patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are children under 11 years old diagnosed with Diamond-Blackfan anemia.
Not a fit: Patients with other types of anemia or those not diagnosed with Diamond-Blackfan anemia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for children with Diamond-Blackfan anemia, improving their quality of life and health outcomes.
How similar studies have performed: Previous research has shown promising results in understanding the mechanisms of glucocorticoids in treating DBA, indicating that this approach has potential for success.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Li, Hojun — University of California, San Diego
- Study coordinator: Li, Hojun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.